Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer

Lung cancer is a leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) being the most common histological type. Owing to the limited therapeutic efficacy and side effects of currently available therapies for NSCLC, it is necessary to identify novel therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yanqin, Li, Jingyang, Yu, Peng, Sun, Jiayi, Hu, Yingfan, Meng, Xianli, Xiang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980082/
https://www.ncbi.nlm.nih.gov/pubmed/35379783
http://dx.doi.org/10.1038/s41420-022-00982-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980082/
https://www.ncbi.nlm.nih.gov/pubmed/35379783
http://dx.doi.org/10.1038/s41420-022-00982-x

Ejemplares similares